quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:39:18·43d
SECFiling
Codexis Inc. logo

SEC Form 10-K filed by Codexis Inc.

CDXS· Codexis Inc.
Industrials
Full content unavailable. See the original source below.
Original source

Companies

  • CDXS
    Codexis Inc.
    Industrials

Recent analyst ratings

  • Aug 19UpdateThe Benchmark Company-
  • Jun 3UpdateJefferies$5.00
  • May 30UpdateCantor Fitzgerald$11.00
  • Feb 29UpdateThe Benchmark Company-
  • Nov 7UpdateThe Benchmark Company-
  • Aug 7UpdateTD Cowen$4.00

Related

  • PR22h
    Codexis to Report First Quarter 2026 Financial Results on May 7
  • SEC9d
    SEC Form 8-K filed by Codexis Inc.
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Codexis Inc.
  • SEC43d
    Codexis Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
  • PR43d
    Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
  • SEC43d
    SEC Form SCHEDULE 13G filed by Codexis Inc.
  • PR50d
    Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
  • INSIDER57d
    Chief Scientific Officer Lutz Stefan sold $6,641 worth of shares (5,862 units at $1.13), decreasing direct ownership by 4% to 130,421 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022